Working… Menu

Safety and Efficacy of Ruxolitinib for COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04348071
Recruitment Status : Withdrawn (Could not make FDA required changes)
First Posted : April 15, 2020
Last Update Posted : March 8, 2021
Information provided by (Responsible Party):
University of Colorado, Denver

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : August 2021
Estimated Study Completion Date : October 2021